Download this whitepaper to learn more.

The biologics development and manufacturing sector has long been at the forefront of innovation, consistently driving therapeutic advancements for a wide array of complex diseases. With market projections indicating a potential $1.37 trillion valuation by 2033, demand has never been greater. However, there are still numerous technical challenges that must be overcome, particularly in the development and production of increasingly complex molecules like bispecific antibodies and heterogeneous proteins.

Access this valuable resource to discover how leading industry organizations are navigating today’s top challenges, while also driving innovation and quality. We explore:

• Successful development strategies for both a standard antibody fragment and a complex heterogeneous molecule
• Implementation of continuous bioprocessing techniques, including perfusion-mode manufacturing and cutting-edge scale-up strategies
• Advanced analytical approaches for ensuring product quality, starting with early-stage development and extending through clinical manufacturing
• Quality by Design (QbD) principles in modern biologics manufacturing, with an emphasis on Critical Quality Attribute (CQA) maintenance
• Solutions for upstream and downstream processing, including resin lifetime optimization and analytical method development
• And more

Don’t miss key insights on how to optimize development and manufacturing processes without compromising quality. Download now!